Skip to main content
Top

CNS Drugs

Issue 6/2014

Content (7 Articles)

Open Access Systematic Review

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

David R. Coghill, Beatriz Caballero, Shaw Sorooshian, Richard Civil

Systematic Review

Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis

O. Beauchet, C. P. Launay, G. Allali, C. Annweiler

Review Article

Role of Atypical Antipsychotics in the Treatment of Generalized Anxiety Disorder

Rachel Hershenberg, Daniel F. Gros, Olga Brawman-Mintzer

Open Access Review Article

Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis

Renaud A. Du Pasquier, Daniel D. Pinschewer, Doron Merkler

Original Research Article

Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response

Juan A. García-León, Carlos López-Gómez, Teresa Órpez-Zafra, Virginia Reyes-Garrido, Carmen Marín-Bañasco, Begoña Oliver-Martos, Oscar Fernández, Laura Leyva

Original Research Article

PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression

David E. Kemp, Martha Schinagle, Keming Gao, Carla Conroy, Stephen J. Ganocy, Faramarz Ismail-Beigi, Joseph R. Calabrese